Peptide Microarray Market Size, Share, Growth, Trends | Report 2022-2030

November 28, 2022 |

7 min read

The peptide microarray market is expected to register a CAGR of 5% during the forecast period.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39891

Peptide Microarray also known as a peptide epitope microarray are the peptides present on the surface of the plastic chip. These plastic chips, also referred to as peptide chips are used to study the binding mechanism and kinetics of the protein-protein interaction. It is the technology that involves high throughput methods in the field of proteomics and clinical assays. Peptide microarray can be analyzed using mass spectrometry, spectroscopy, and imaging via fluorescence. It has a wide range of applications in the field of pharmacology, medicine, and biology.

It is one of the automated advanced technology to collect large data from a single experiment used for disease diagnosis, therapeutic discoveries, and diagnostic techniques development. The technique is used to identify new drug targets. To locate the antigen, present on the protein surface of bacteria, immunogenic Identification, determination of Abs, mapping of the epitope, enzyme characterization, biomarker validation, serum profiling, and HLA profiling are some of the applications of the peptide microarray. Following are the advantages of peptide microarrays:

Cost-effective
Flexible design of the sequence of the peptides
High batch-to-batch reproducibility
Extended shelf strength

In recent years, with the increase in the prevalence of chronic diseases, there is an increase in the demand for molecular diagnostic techniques. Moreover, peptide microarray diagnostic techniques are cost-effective and economical which drives the market. In January 2020, the company named PEPperPRINT launched the proteome-wide peptide microarray which includes COVID-19 2019-nCoV coronavirus. It is used to detect and locate the IgG and IgM Abs present in the patient serum. This is done for the diagnostic tests for vaccine production. This is one of the drivers to accelerate the market forecast.

The key players are also investing in R&D to develop solutions and products for the early diagnosis and treatment of chronic disease. Thus, companies are adopting the advanced technologies of microarray which drives the global microarray market. Moreover, the lack of technical complications in the microarray technology can be a restraining factor.

The market is segmented based on product, application, end-user, and region. The product segment is classified into instruments, reagents, and services. The application segment is segmented into therapeutic vaccine production, proteomics, diagnostics, protein functional analysis, and antibody characterization. The end-user segment is further segmented into pharmaceutical and biotechnology companies, hospitals and clinics, diagnostic centers, and private laboratories.

Based on the regions the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominates the market. The large share is mainly attributed to the developed healthcare facilities in this region along with increasing expenditure in the R&D sector. Also, there is awareness among healthcare workers and people with early diagnosis and treatment of chronic disease which accelerates the diagnostic capabilities in this region and boosts the market. The majority of key players are also present in North America which fuels the market growth.

Key Market Trends

The Instrument Segment is Expected to Hold a Major Market Share in the Peptide Microarray Market

The instrument segment is expected to witness good growth in the market and is anticipated to show a similar trend over the forecast period, owing to technologically advanced peptide microarray products and various types of research in chronic disorders, such as cancer, autoimmune and infectious disease. For instance, PEPperPRIINT offers PEPperCHIP Standard Peptide Microarrays, which cover epitopes, antigens, and viral proteomics, and is widely used in various types of research (allergen, cancer, and signature discovery). Moreover, these are also used for antibody epitope mapping, biomarker discovery, immune monitoring, detection, and validation for protein interaction. For instance, JPT Peptide Technologies has a product PepStar Peptide Microarrays, which helps in enzyme profiling and identifies a substrate for orphan enzymes. The research and development of peptide products are increasing as they are cost-effective, efficient, and have lower toxicity. In September 2021, Nimble Therapeutics, a biotechnology company involved in the discovery and development of peptide therapeutics, reported that their strategic research collaboration with Incyte has been expanded to include the discovery of additional novel peptide therapies. Similarly, in November 2020, PEPperPRINT announced a partnership with Lucerna-Chem. Under a new distribution agreement, customers in Switzerland can now additionally avail of PEPperCHIP Peptide Microarray products and PEPperMAP Services through Lucerna-Chem. Thus, such agreements are expected to increase market growth by providing advance instruments in the region.

Thus, the abovementioned factors are expected to increase the market growth.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39891

COVID-19 Impact

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

COVID-19struck the heart of the world’s food value networks, producing widespread disruptions that had repercussions throughout the supply chain, from production to processing and distribution. Containment efforts established by national governments to control the spread of the coronavirus were the catalyst for all of these repercussions, which resulted in major paradigm shifts.

key questions
• What are the prominent leaders in the market?
• What is the share and the growth rate of the Peptide Microarray market during the forecast period?
• What are the future prospects for the Peptide Microarray industry in the coming years?
• Which trends are likely to contribute to the development rate of the industry during the forecast period, 2022 to 2030?
• What are the future prospects of the Peptide Microarray industry for the forecast period, 2022 to 2030?
• Which companies are dominating the competitive landscape across different region and what strategies have they applied to gain a competitive edge?
• What are the major factors responsible for the growth of the market across the different regions?
• What are the challenges faced by the companies operating in the Peptide Microarray market?

Related Reports